1Kumar S,Bhatia M,Behari M.Sleep disorders in Parkinson's disease.Mov Disord,2002,17:775～781.
2Lees AJ,Blackburn NA,Campbell VL.The nighttime problems of Parkinson's disease.Clin Neuropharmacol,1988,11:512～519.
3Happe S,Berger K,FAQT Study Investigators.The association of dopamine agonists with davtime sleepiness,sleep problems and quality of life in patients with Parkinson's disease-a prospective study.J Neurol,2001,248(12):1062～1067.
4Cantor CR,Stern MB.Dopamine agonists and sleep in Parkinson's disease.Neurology,2002,58(4 Suppl 1):S71～78.
5Gjerstad MD,Aarsland D,Larsen JP.Development of daytime somnolence over time in Parkinson's disease.Neurology,2002,58(10):1544～1546.
6Pal S,Bhattacharya KF,Agapito C,et al.A study of excessive daytine sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole,cabergoline and levodopa mono and combination therapy.J Neural Transm.2001,108(1):71 ～77.
7Gjerstad MD,Aarsland D,Larsen JP.Development of daytime somnolence over time in Parkinson's disease.Neurology, 2002,58(10):1544～1546.
8Montastruc JL,Brefel-Courbon C,Senard JM,et al.Sleep attacks and antiparkinsonian drugs:a pilot prospective pharmaeoepidemiologie study.Clin Neuropharmacol,2001,24(3):181 ～183.
9Hobson DE,Lang AE,Martin WR,et al.Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease:a survey by the Canadian Movement Disorders Group.JAMA,2002,287(4):455～463.
10Boeve BF.Silber MH,Ferman TJ,et al.Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy.Mov Disord,2001,16(4):622～630.
